Child METHOD We systematically reviewed non-pharmacological interventions aimed at improving non-respiratory sleep disturbance in children with neurodisability. Sixteen databases, grey literature, and reference lists of included papers were searched up to February 2017. Two researchers (B.B., C.M., G.S., A.S., A.P.) undertook screening, data extraction, and quality appraisal.
INTERPRETATION Various types of non-pharmacological intervention for managing sleep disturbance have been evaluated. Clinical heterogeneity and poor study quality meant we could not draw definitive conclusions on the effectiveness of these interventions. Current clinical guidance recommends parent-directed interventions as the first approach to managing sleep disturbance; prioritizing research in this area is recommended.
Non-respiratory sleep disturbances are more prevalent in children with neurodisabilities than in typically developing children. 1, 2 Sleep problems can affect quality of life, school performance, and daytime behaviour. 3, 4 Child sleep problems are also associated with poor outcomes for parents and other members of the household. 5 Current guidance on management of sleep disturbance in children proposes that once clinical or respiratory reasons for sleep disturbance are excluded, interventions that aim to change parents' management of their child's sleep should be the 'first port of call'. 6 This guidance is regarded as applicable to children with neurodisability. Pharmacological interventions (such as melatonin) are recommended where such interventions prove ineffective or alongside parent-directed approaches. 7, 8 Other non-pharmacological approaches include chronotherapy, phototherapy, dietary interventions, sensory interventions (e.g. weighted blankets), cranial osteopathy, and environmental changes.
Previous systematic reviews in the field of managing sleep disturbance in children with neurodisabilities have mainly focused on individual diagnoses [9] [10] [11] [12] [13] [14] and/or a specific intervention or pharmacological intervention only. 10, [13] [14] [15] A systematic review was therefore commissioned by the UK National Institute for Health Research (NIHR), Health Technology Assessment (HTA) Programme to collate the existing evidence across multiple interventions and neurodisabilities.
We aimed to assess the effectiveness of non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities and to identify priorities for future primary research. The review reported here is part of a broader review, which also included pharmacological interventions and will be available as an NIHR HTA
Outcomes
The primary outcomes of interest were child-and parentrelated sleep. These included actigraphy-based and parent/ carer-or child-reported measures (e.g. sleep diaries, or standardized scales relating to initiation, maintenance, scheduling, or quality of sleep).
Secondary outcomes included child-related quality of life; daytime behaviour and cognition; parent/carer quality of life and well-being including global quality of life, physical well-being, mental well-being, mental health (e.g. stress) and family functioning; and adverse events.
Study design
Randomized controlled trials (RCTs), non-randomized controlled studies, and before-and-after studies were eligible. Case studies were excluded.
Search strategy
An information specialist searched the following electronic databases in February and March 2016 and updated the search in February 2017: Applied Social Sciences Index of Abstracts (ASSIA); The Cochrane Central Register of Controlled Trials (CENTRAL); Cochrane Database of Systematic Reviews; Conference Proceedings Citation Index; Cumulative Index of Nursing and Allied Health Literature (CINAHL); Database of Abstracts of Reviews of Effects; Embase; Health Management Information Consortium; MEDLINE; MEDLINE In-Process; PsycINFO; Science Citation Index; Social Care Online; and Social Policy & Practice. ClinicalTrials.gov; World Health Organization International Clinical Trials Registry Platform; and the UK Clinical Trials Gateway were also searched for ongoing and completed trials. An example search strategy (for ASSIA) is provided in Appendix S1 (online supporting information). There were no restrictions on date, language, or study design.
Study selection and data extraction
The search results were downloaded into Endnote bibliographic software (Clarivate Analytics, Philadelphia, PA, USA) and deduplicated. The first 10% of titles were screened independently by two researchers (B.B., C.M., G.S., A.S., A.P.). Once agreement had been reached, a single researcher (A.S., A.P.) screened the remainder. Two researchers (B.B., C.M., G.S., A.S., A.P.) independently screened the abstracts of the records identified as potentially relevant on the basis of their title. Full papers were independently screened by two researchers (B.B., C.M., G.S., A.S., A.P.). Discrepancies were resolved through discussion and consensus with a third researcher (C.M.) if necessary. Data extraction forms were developed and piloted in Microsoft Word 2010 and Excel 2010. Data extracted included details of study design, descriptions of the intervention and comparator, outcome measures, and methods of assessment. Outcome data were extracted to allow calculation of the mean difference and 95% confidence interval (CI) between groups to assist comparison between studies. Data extraction was undertaken by one researcher and checked by a second (A.S., A.P.).
Quality assessment
Risk of bias was assessed using the Cochrane Risk Of Bias Tool for RCTs, 21 A Cochrane Risk Of Bias Assessment Tool for Non-Randomized Studies of Interventions for other studies with a control group, 22, 23 or an adapted
What this paper adds
• Existing evidence on non-pharmacological interventions to manage sleep disturbance in children with neurodisabilities is predominately of poor quality.
• Most included studies evaluated parent-directed interventions of varying content and intensity.
• There was very little consistency between studies in the outcome measures used.
• There is some evidence that parent-directed interventions may improve child outcomes.
Review 1077 checklist for before-and-after studies. 24 For crossover trials, we also assessed whether an appropriate analysis using paired data was conducted and whether there was a treatment-by-period interaction. 25 Assessment of risk of bias was undertaken independently by two researchers (B.B., C.M., G.S., A.S., A.P.), with discrepancies resolved through consensus, or discussion with a third researcher (C.M.).
Strategy for data synthesis
The substantial heterogeneity of interventions, study design, and outcome measures across studies meant meta-analysis was not appropriate. Therefore, narrative summaries are used to describe the available evidence. Interventions were assigned to the following categories: parent-directed and 'other' non-pharmacological interventions (Appendix S2, online supporting information).
Parent-directed interventions were defined as psychoeducational interventions aiming to teach parents knowledge and skills to manage their child's sleep disturbance and possibly to provide support to parents as they implement new knowledge and skills. Modes of delivering such interventions include one-to-one sessions, group work, one-off workshops, and provision of written material. Given the variety within this category of intervention, these were classified in terms of their content (comprehensive vs non-comprehensive) and the degree to which they were personalized to the individual child (tailored vs nontailored). The following intervention typology was created: (1) Comprehensive tailored: a detailed assessment guides the decision-making regarding the management of a specific child's sleep disturbance. A sleep management plan specific to the child/family is developed, and training in implementing that plan is delivered. There is ongoing support and advice as parents implement changes to sleep management strategies and practices ('implementation support'). A comprehensive approach is used involving training across sleep and sleep processes, sleep hygiene, and the management of specific problem behaviours (e.g. night wakings). (2) Comprehensive non-tailored: a standard 'training curriculum' is used which is comprehensive in content and may include opportunities for a parent to be supported to operationalize the material learnt to their child's sleep disturbance. Implementation support may also be included. (3) Non-comprehensive: intervention focuses on a single topic area related to managing sleep disturbance (e.g. sleep hygiene, behavioural strategies); these may be tailored or non-tailored. Other types of non-pharmacological intervention included interventions such as complementary therapies and weighted blankets.
Studies were grouped by intervention type, study objective (evaluations of intervention effectiveness, evaluations of different modes of delivering an intervention or intensity of support), and then by study design (RCT and nonrandomized study designs) for the synthesis.
RESULTS

Overview of the evidence
After deduplication, 15 745 titles were screened and 25 studies investigating non-pharmacological interventions were included (Fig. 1) . A list of excluded studies is available from the authors. Table I summarizes key study characteristics, grouped by the type of intervention evaluated. Eleven RCTs, one controlled before-and-after study, and 14 uncontrolled before-and-after studies were included. Studies were conducted in the UK (n=9), USA (n=7), Australia (n=5), and one each in Canada, Hong Kong, Israel, and China. Sample sizes ranged from 5 to 244 participants.
The mean age of children ranged from 2 years 8 months to 12 years 1 month. Thirteen studies included children with two or more neurodisabilities. In nine studies, participants were described as having a single neurodisability diagnosis: autism spectrum disorder (n=6) or attention-deficithyperactivity disorder (ADHD) (n=3). The remaining three studies offered no detail on the types of neurodisability represented; generic terms such as 'mental retardation' were used. Most studies included children with a mix of sleep disturbances, with the most commonly reported being sleep initiation and maintenance (n=14 studies). The first timepoint at which outcomes were measured once the intervention was completed ranged from immediately after intervention to 2 months after intervention. Five trials collected outcome data at additional follow-up time points; however, to minimize heterogeneity in results we only report outcomes measured closest to the end of the intervention.
Risk of bias
Poor reporting of study methods and results was found across all study designs. All RCTs were assessed as having high risk of bias for most items on the Cochrane Risk of Bias tool because of issues with randomization and incomplete outcome data. We were unable to find a registered protocol for 10 RCTs, 5, [26] [27] [28] [29] [30] [31] [32] [33] [34] and in all RCTs blinded outcome assessment was either not undertaken or it was unclear whether blinding had occurred. 5, [26] [27] [28] [29] [30] [31] [32] [34] [35] [36] However, we do note that the type of interventions and outcomes under investigation make robust, blinded outcome assessment challenging. Although the use of actigraphy data may be considered more objective than parentreported data in terms of the measurement of some sleep outcomes, we did not consider these to be true objective outcomes with non-blinding likely to introduce bias.
Non-randomized studies were at high (n=12) or unclear (n=2) risk of bias. This was mainly because of how studies selected participants (e.g. not reporting eligibility criteria) [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] and likely or unclear bias in measurement of intervention outcomes. 39, 40, [43] [44] [45] [46] 51 Outcomes Seventy-one sleep-related outcomes were reported across the included studies. Given the number of outcomes assessed, in this paper we only report the two most commonly measured outcomes: Child Sleep Habits Questionnaire (CSHQ), 52 and sleep onset latency (SOL). The CSHQ is a parent-report questionnaire which is widely used to measure sleep disturbance. The questionnaire has 33 items, rated on a 3-point Likert scale. Items are grouped into the following subscales: bedtime resistance, sleep onset delay, sleep duration, sleep anxiety, night wakings, parasomnias, sleep disordered breathing, and daytime sleepiness. A total score offers an overall measure of sleep disturbance, with higher scores indicating a greater severity of sleep disturbance, owing to either the frequency (i.e. regularity) or number of different behaviours presenting. However, caution is needed when using the scale as the sole method of assessing a child's sleep problems as a number of subscales showed low construct validity and diagnostic validity. 53 No clinically important difference has been established for either the CSHQ or SOL. At least one of these outcomes was reported by most included studies. Six studies did not report either of these outcomes. 26, 34, 36, 37, 43, 46 Full data on all outcomes are provided in the HTA report (https://www.journalslibrary.nihr.ac.uk/ programmes/hta/1421202/#/).
Results from studies Parent-directed: comprehensive tailored interventions Five RCTs 5, [27] [28] [29] 35 and four before-and-after stud- Review 1079 Associated papers [64] [65] [66] UK Before-and-after study delivered face-to-face (at home and/or in clinic) ( Table II) . The duration of the intervention, the number of sessions delivered, and the extent of implementation support varied across studies. Of the five RCTs, three used a no-intervention comparator, 27, 28, 35 and two evaluated alternative ways of delivering an intervention: one compared the mode of implementation support (home visit vs telephone call); 5 and the other compared the intensity of practitioner involvement when delivering the intervention (brief vs extended). 29 CSHQ. Four RCTs (n=310) 5, 28, 29, 35 and two before-andafter studies (n=20) 5, 50 reported the CSHQ total score, a validated parent-reported global assessment of child sleep (Table III) . One RCT, which was classified as having low risk of bias on all domains except for performance bias (n=244), reported a statistically significant reduction (i.e. improvement) in total CSHQ score after intervention for the ADHD-specific intervention compared with usual care (adjusted mean difference À6.6, 95% CI: À8.5 to À4.6).
35
Another smaller RCT (n=26) reported a similar magnitude of effect but was not statistically significant (mean difference À4.62, 95% CI: À10.83 to 1.59). 28 In one beforeand-after study there was an improvement in total CSHQ score after intervention compared with preintervention (mean difference À7.9, 95% CI: À14.4 to À1.3).
50
For the two trials investigating alternative approaches to delivering the intervention, no statistically significant difference in CSHQ score was observed. 5, 29 SOL. One RCT (n=40) 27 and two before-and-after studies (n=21) 50, 51 measured SOL, the time from bedtime to sleep onset. There was no statistically significant difference in actigraphy-measured SOL (verified using sleep diaries) Review 1083
in the RCT of a comprehensive tailored intervention compared with an attention placebo control (non-sleep-related parent education) (mean difference 4min, 95% CI: À15.0 to 23.0). 27 One before and after the study also reported no statistically significant difference before and after the intervention in sleep-diary-measured SOL (mean difference 43min, 95% CI: À30 to 116); 50 the second presented the results as graphs with no numerical data available. 51 
Parent-directed: comprehensive non-tailored interventions
Three RCTs and five before-and-after studies evaluated comprehensive non-tailored interventions. 26, 30, 31, 38, 44, 48, 54 Various modes of delivery were used across the studies (Table IV) . They also varied in the extent to which they accommodated the specific information and training needs parents might have had for their child's condition and/or sleep problem. Some included telephone implementation support, whereas others did not.
One RCT compared a sleep training curriculum delivered by a booklet with no intervention; 30 one compared two modes of delivering the same curriculum group versus individual face-to-face sessions supplemented by weekly telephone calls; 31 and one compared group with individual delivery of a training curriculum. 26 The before-and-after studies evaluated a group-delivered intervention; 38,42,48 a single session workshop; 41 and an individually delivered intervention. 44 CSHQ. One RCT (n=80) 31 and four before-and-after studies (n=126) 38, 41, 42, 48 reported CSHQ total score. The RCT reported no statistically significant difference for this outcome between delivery of the training curriculum via a group or a single face-to-face session (not possible to calculate effect estimate and 95% CI). 31 Two before-and-after studies, one evaluating a three-session group-delivered intervention 48 and the other a four-session group-delivered intervention plus implementation support, 38 reported statistically significant improvements (i.e. a decrease) in CSHQ total score after intervention compared with preintervention (mean difference À6.9, 95% CI: À2.6 to À11.2 48 and mean difference À3.3, 95% CI: À1.4 to À5.3 38 respectively). For the two other before-and-after studies, the mean difference in total CSHQ score could not be calculated before and after the intervention as the samples were not matched. However, the studies reported small or very small effect sizes of 0.20 and 0.02. 41 SOL. Two RCTs (n=116) 30, 31 and two before-and-after studies (n=40) 44, 48 reported SOL. No statistically significant difference in SOL was observed in the RCT comparing a non-tailored intervention with no intervention (mean difference À11.8, 95% CI: À37.3 to 13.7), 30 the RCT comparing individual versus group delivery of the same training curriculum (mean difference À0.2, 95% CI: À9.9 to 9.5), 31 or in the before-and-after study of a group-delivered intervention (data not presented, narrative report provided only). 48 The second before-and-after study reported a statistically significant reduction in SOL after receipt of a non-tailored comprehensive intervention delivered by a single face-to-face session (mean difference À42.8, 95% CI: À6.01 to À24.6).
44
Parent-directed: non-comprehensive interventions
One RCT and one before-and-after study 34 ,47 evaluated non-comprehensive interventions (Table V) .
The RCT (n=30) evaluated an intervention that focused specifically on behavioural principles of managing problem sleep. 34 The comparator was an attention control. Neither CSHQ nor SOL were reported in this study. The beforeand-after study (n=23) evaluated an intervention 47 that trained parents of children with ADHD on the principles of sleep hygiene only. This study reported a statistically significant improvement in CSHQ total score at 6 weeks after intervention (mean difference 6.4, 95% CI: 4.3-8.5).
Other non-pharmacological interventions
Two RCTs and four before-and-after studies evaluated other types of non-pharmacological intervention (Tables I  and VI) . 32, 36, 37, 39, 40, 46 CSHQ. One study reported the CSHQ; there was a statistically significant reduction in total CSHQ score in the before-and-after study after acupuncture and ear point taping (mean difference À11.5, 95% CI: À13.3 to À9.7). As not a matched sample (n=11 preintervention and n=7 postintervention). I, intervention; C, comparator; NR, Not reported Before-and-after studies Guilleminault et al. 37 Light therapy and behavioural programme Light therapy and behavioural programme.
39
Children were exposed to bright light (sunlight or artificial). The behavioural programme involved scheduled parent child interaction; scheduled naps for younger children; avoidance of naps for older children; scheduled lunch; scheduled sleep time SOL. One RCT (n=73) 32 and one before-and-after study (n=8) 40 measured SOL. There was no statistically significant difference for this outcome in the RCT comparing weighted blankets with placebo blankets 32 (actigraphy-measured SOL: mean difference 2.1, 95% CI: À5.5 to 9.7; parent reported: mean difference À1.6, 95% CI: À6.7 to 3.5). There was also no statistically significant difference in parent-reported SOL in a before-and-after study evaluating an aquatic exercise intervention (mean difference 19.11, 95% CI: À40.95 to 6.57). 40 
DISCUSSION
Principal findings
This systematic review has identified a lack of high-quality evidence assessing the effectiveness of non-pharmacological interventions to manage sleep disturbance in children with neurodisabilities.
Three-quarters of the studies evaluated parent-directed interventions. We found no replication of studies or more than one study evaluating the same intervention. This lack of evidence is noteworthy given that parent-directed interventions are recommended as the 'first port of call' for clinicians seeking to manage sleep disturbance in children with neurodisabilities. Less than half the evidence came from RCTs, and all of these had substantial or unclear risk of bias; therefore their findings need to be treated with some caution.
Several of the parent-directed interventions showed evidence of benefit. One before-and-after study reported a significant reduction in SOL after a comprehensive nontailored intervention delivered by a single face-to-face session. 44 In relation to total CSHQ score, one RCT of a comprehensive tailored intervention developed specifically for children with ADHD, and rated as being at low risk of bias for all domains except blinding, 35 reported a statistically significant improvement on this outcome measure. Additionally, two before-and-after studies evaluating comprehensive non-tailored interventions delivered via groups, 38, 48 and one before-and-after study of a non-comprehensive intervention (ADHD-specific) also showed statistically significant improvements in total CSHQ score. 47 As far as we are aware, a minimum clinically important difference for the CSHQ has not yet been established; therefore the clinical significance of these findings is unclear. We would note that where RCTs did not show evidence of statistically significant benefit for outcomes, this too needs to be interpreted cautiously as 'no evidence of effect' does not mean there is 'evidence of no effect'. 54 For the RCTs that were comparing parent-directed interventions in terms of mode of delivery or intensity of support, the evaluation question is different and is concerned with comparing the effectiveness of alternative (in the case of this review, more and less resource intensive) ways of providing an intervention. 5, 27, 29, 31 In three of these trials, 5, 29, 31 no significant differences in outcomes, as assessed by CHSQ scores and/or SOL, were reported. The remaining trial 27 did not use these outcome measures. Again, we reiterate the caution with which these findings should be treated given the reported issues with study quality, the lack of any replication, and the absence of a rubric by which the clinical significance of observed effects can be judged.
Comparison with other research
Our results support the findings of Brown et al., 55 who, in 2013, reviewed evidence on non-pharmacological interventions to manage sleep disturbance in children with neurodevelopmental disorders, or cognitive and/or visual impairment. Their preliminary scoping searches suggested that most studies, particularly those with a more robust design, had not yet reported and so it was considered too early to attempt a systematic review of RCTs. Instead, the authors conducted a critical review and concluded that there is little conclusive evidence on non-pharmacological interventions in this population. In contrast, a recent systematic review of parent-directed sleep management interventions for non-disabled children aged 5 years and under concluded that there was 'moderate support' for these interventions. The authors recommended parent-directed interventions to be implemented without hesitation for typically developing young children. 56 Existing evidence on non-pharmacological interventions for sleep disturbance in children with neurodisabilities provides little clarity as to the effectiveness of these interventions. Given the poor quality and inconclusive nature of available evidence, there is a need for high-quality RCTs assessing their effectiveness and cost-effectiveness. This needs to include trials evaluating the relative effectiveness of alternative ways of delivering interventions. In addition, given the nature of parent-directed interventions, trials should be designed so that the impact of relevant parent, child, and impairment characteristics on effectiveness can be tested. In 2017, Sciberras et al. 57 published a protocol for a large RCT (n=320) that assessed the effectiveness and costeffectiveness of a comprehensive tailored intervention in improving sleep in children with ADHD. Described as a translational study, it evaluated one of the interventions included in this review 34 in terms of effectiveness (and cost-effectiveness) when delivered in clinical settings by paediatricians or psychologists. Recruitment to this trial was completed in October 2016; however, findings have not yet been published. This RCT will make an important contribution to the evidence base when the results are reported. However, given the diversity of the patient group and the number of non-pharmacological interventions available, additional RCTs and replication studies -conducted in settings where the intervention can be delivered as routine practice and across all (relevant) neurodisabilities -are required. Finally, going forward, we would note the importance of detailed reporting of the interventions using a standardized checklist for describing complex interventions. 58 
Strengths and weaknesses of the research
This review provides a comprehensive overview of the evidence available on non-pharmacological interventions to manage sleep disturbance for children with neurodisabilities. We present only the most commonly reported child sleep outcomes in this paper owing to the vast number of unique outcome measures reported. The full results will be available in an NIHR HTA report (https://www.journal slibrary.nihr.ac.uk/programmes/hta/1421202/#/), which reaches the same conclusions as drawn in this paper. We undertook systematic searches of 16 databases for published, unpublished, and ongoing studies. There were no language restrictions and we included one study published in Chinese. As with all systematic reviews, there was a passage of time between the last date of the literature searches (February 2017) and publication. As a result, there may be one or more studies that have subsequently been published which meet our review's inclusion criteria that are not included here. Our searches of trial registries identified five trials that will be completing over the next couple of years, so an update to this review may then be warranted. Standard methods to reduce error and bias at key stages of the review were used. For example, screening and quality assessment were undertaken independently by two researchers (B.B., C.M., G.S., A.S., A.P.). We developed a typology of parent-directed interventions in the way we believe was most meaningful after discussion among members of the team. We hope this makes a useful conceptual contribution to understanding and specifying such interventions. Although others may have found an alternative way to group these interventions, we do not believe it would change the conclusions of this review. We strictly followed the guidance for completing the Cochrane Risk of Bias tool, meaning that studies were downgraded for lack of blinding, which is difficult to achieve with these types of intervention. This affected one study, which had a low risk of bias on all other criteria. 35 Had we applied the Cochrane criteria 'less strictly', this study would have been rated as having low risk of bias. (It is this intervention that is, as noted earlier, currently subject to a translational trial). 57 This raises an important issue for studies in this area, as classifying studies as having a high risk of bias will mean that non-pharmacological evidence will always seem weaker than studies of pharmacological evidence. At the same time, in the absence of an established method of blinded outcome assessment, there is a risk of overestimating the effectiveness of an intervention where allocation is unblinded and parent-reported outcomes have an element of subjectivity.
Unanswered questions and further research
The substantial health, social, and economic effects of sleep deprivation mean this lack of robust evidence needs to be addressed. A recent UK national research prioritization exercise for children with neurodisability ranked the management of sleep disturbance in the top 10 research priorities. 59 We therefore argue for strategic investment on this topic and our proposed research recommendations are set out below.
However, we note that, on the basis of this review's findings, it is difficult to closely specify where such Review 1089 research should be focused. We suggest that attention is paid to interventions that are feasible to deliver in routine practice. Furthermore, acknowledging the resource constraints of public services and, as was done by some studies reviewed and where appropriate, evaluations should compare lower and higher intensity modes of delivery (e.g. direct vs remote contact between parent and professional; qualifications of staff delivering the intervention; text-based information/advice vs face-to-face session). Finally, we would argue there is no strong case for developing new interventions. Going forward, the focus should be on further evaluation of existing interventions that appear, on the basis of this review, to have some degree of promise, have (if relevant) been manualized, and are relevant to the ways in which health care is delivered.
First, high-quality RCTs assessing non-pharmacological interventions for sleep disturbance in children with neurodisability are needed. These RCTs should assess the key questions of what works, for whom, and in what circumstances. Intervention development would benefit from being informed by mixed methods research into the mechanisms by which non-pharmacological interventions may affect a child's sleep. A theory-driven approach to intervention development and evaluation is essential if we are to gain understanding of an intervention's active ingredients and the factors that may moderate or mediate their therapeutic action. [60] [61] [62] Second, non-pharmacological interventions for managing sleep disturbance in children with neurodisability are 'complex interventions', made up of several interacting elements. Future research may benefit from adopting the UK Medical Research Council's framework on developing and evaluating complex interventions. 63 This would enable robust approaches to the development and evaluation of complex interventions to be adopted that are grounded in theory. 60 Future research publications should ensure that interventions are described in sufficient detail for replication, for example through use of the Template for Intervention Description and Replication (TIDieR) checklist. 58 Third, none of the included studies were presented as preventive interventions. The brief, less intense, parentdirected interventions reviewed may align with a preventive or early intervention approach. Evaluating the impact of these interventions on preventing the development of sleep disturbance, or preventing a newly emerging sleep disturbance increasing in severity, would be beneficial.
Fourth, future evaluations should include an economic evaluation, including consideration of costs to families as well as to service providers.
Finally, future research to establish a method of blinded outcome assessment in this area would be beneficial. Additionally, methodologists may wish to consider how to grade lack of blinding in studies where blinding is not possible and outcomes are subjective.
CONCLUSIONS
A wide range of non-pharmacological interventions have been evaluated for managing sleep disturbance in children with neurodisabilities. Although there is some evidence that parent-directed interventions may improve outcomes for children, it was not possible to draw definitive conclusions owing to the lack of robust evidence and substantial heterogeneity across studies. Current clinical guidance recommends parent-directed interventions should be the first approach to managing sleep disturbance; prioritizing research in this area is therefore recommended. M ETODOS Revisi on sistem atica de intervenciones no farmacol ogicas destinadas a mejorar la alteraci on del sueño de causa no respiratorio en niños con discapacidades neurol ogicas. Se realizaron b usquedas en diecis eis bases de datos, literatura gris y listas de referencias de documentos incluidos hasta febrero de 2017. Dos investigadores llevaron a cabo ex amenes de detecci on, extracci on de datos y evaluaci on de la calidad.
RESULTADOS Se incluyeron veinticinco estudios: 11 estudios controlados aleatorios (ECA) y 14 estudios observacionales -antes y despu es. Todos los estudios ten ıan un riesgo de sesgo alto o poco claro. Las intervenciones dirigidas a los padres se categorizaron como: intervenciones integrales a medida (n = 9), intervenciones integrales no adaptadas (n = 8), intervenciones no integrales (n = 2). Seis "otras" intervenciones no farmacol ogicas se incluyeron. Se midieron los resultados relacionados con el sueño de 71 niños y padres a trav es de los estudios incluidos. Presentamos los dos resultados m as com unmente medidos: Cuestionario de H abitos de Sueño Infantil y Latencia de Inicio del Sueño. Cinco estudios informaron mejoras significativas en al menos uno de estos resultados.
INTERPRETACI ON Se han evaluado diversos tipos de intervenciones no farmacol ogicas para controlar la alteraci on del sueño.
Debido a la heterogeneidad cl ınica y la mala calidad de los estudios no pudimos sacar conclusiones definitivas sobre la efectividad de estas intervenciones. La gu ıa cl ınica actual recomienda las intervenciones dirigidas por los padres como el primer enfoque para manejar la alteraci on del sueño; se recomienda priorizar la investigaci on en esta area. Registro de revisi on: registro de PROSPERO: CRD42016034067
